1 |
Sarnaik MK, Modi S, Pisipati Y, Vaidya S, Syed Gaggatur N, Sange AH, Srinivas N, Sange I. Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol. Cureus 2021;13:e16744. [PMID: 34354892 DOI: 10.7759/cureus.16744] [Reference Citation Analysis]
|
2 |
Al-Marhabi A, Hashem A, Zuberi BF, Onyekwere C, Lodhi I, Mounir M, Alkhowaiter S, Al Awadhi S, Naidoo VG, Hamada Y. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Rev Gastroenterol Hepatol 2022;16:217-33. [PMID: 35184616 DOI: 10.1080/17474124.2022.2043744] [Reference Citation Analysis]
|
3 |
Brusselaers N, Sadr-Azodi O, Engstrand L. Proton pump inhibitors and the risk of pancreatic cancer. J Gastroenterol 2021;56:295-6. [PMID: 33527212 DOI: 10.1007/s00535-021-01761-8] [Reference Citation Analysis]
|
4 |
Rückert-Eheberg IM, Nolde M, Ahn N, Tauscher M, Gerlach R, Güntner F, Günter A, Meisinger C, Linseisen J, Amann U, Baumeister SE. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018. Eur J Clin Pharmacol 2021. [PMID: 34877614 DOI: 10.1007/s00228-021-03257-z] [Reference Citation Analysis]
|